Advances in Anticancer Drug Discovery: Design, Synthesis and Molecular Insights
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 36
Special Issue Editor
Interests: drug discovery; medicinal chemistry; drug design; anticancer agents; metallodrugs; bioinorganic chemistry; molecular imaging; theranostics
Special Issue Information
Dear Colleagues,
The development of novel anticancer drugs requires a combined approach involving molecular design, synthetic strategies, and mechanistic studies to identify lead compounds with therapeutic potential. This Special Issue invites contributions addressing the rational design, synthesis, and biological evaluation of innovative anticancer compounds. Particular attention will be given to studies clarifying structure–activity relationships, mechanisms of action, and target(s) interactions that provide insight into cancer biology and treatment. As IJMS is a molecular science journal, purely clinical studies are not suitable; nonetheless, clinical or model submissions with biomolecular experiments are welcomed, ensuring the link between preclinical studies and therapeutic applications.
Dr. Michele De Franco
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer agents
- drug design
- drug synthesis
- structure-activity relationship (SAR)
- target interactions
- medicinal chemistry
- lead optimization
- targeted therapy
- bioactive compounds
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
